{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:30:59Z","timestamp":1782977459522,"version":"3.54.5"},"reference-count":201,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2018\/SKK08\/IMU\/02\/2"],"award-info":[{"award-number":["FRGS\/1\/2018\/SKK08\/IMU\/02\/2"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-024-01368-x","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T07:01:46Z","timestamp":1717657306000},"page":"985-1004","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Blood-based therapies to combat neurodegenerative diseases"],"prefix":"10.1007","volume":"39","author":[{"given":"Jia Yee","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervyn Chen Xi","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhun Yian","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Tze","family":"Tsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0060-2576","authenticated-orcid":false,"given":"Soi Moi","family":"Chye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,6]]},"reference":[{"key":"1368_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000068158","volume":"12","author":"GM Abouna","year":"2003","unstructured":"Abouna GM (2003) Ethical issues in organ transplantation. Med Princ Pract 12:54\u201369. https:\/\/doi.org\/10.1159\/000068158","journal-title":"Med Princ Pract"},{"key":"1368_CR2","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1021\/MP300214K","volume":"10","author":"L Abuqayyas","year":"2013","unstructured":"Abuqayyas L, Balthasar JP (2013) Investigation of the role of Fc\u03b3R and FcRn in mAb distribution to the brain. Mol Pharm 10:1505\u20131513. https:\/\/doi.org\/10.1021\/MP300214K","journal-title":"Mol Pharm"},{"key":"1368_CR3","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1002\/JUM.14256","volume":"36","author":"T Alecou","year":"2017","unstructured":"Alecou T, Giannakou M, Damianou C (2017) Amyloid \u03b2 plaque reduction with antibodies crossing the blood-brain barrier, which was opened in 3 sessions of focused ultrasound in a rabbit model. J Ultrasound Med 36:2257\u20132270. https:\/\/doi.org\/10.1002\/JUM.14256","journal-title":"J Ultrasound Med"},{"key":"1368_CR4","unstructured":"Arumugham VB, Rayi A (2022) Intravenous Immunoglobulin (IVIG). In: StatPearls. StatPearls Publishing, Treasure Island (FL). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554446\/"},{"key":"1368_CR5","doi-asserted-by":"publisher","first-page":"7873","DOI":"10.1523\/JNEUROSCI.22-18-07873.2002","volume":"22","author":"BJ Bacskai","year":"2002","unstructured":"Bacskai BJ, Kajdasz ST, McLellan ME et al (2002) Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy. J Neurosci 22:7873\u20137878. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-18-07873.2002","journal-title":"J Neurosci"},{"key":"1368_CR6","doi-asserted-by":"publisher","first-page":"7131","DOI":"10.1038\/NCOMMS8131","volume":"6","author":"GS Baht","year":"2015","unstructured":"Baht GS, Silkstone D, Vi L et al (2015) Exposure to a youthful circulaton rejuvenates bone repair through modulation of \u03b2-catenin. Nat Commun 6:7131. https:\/\/doi.org\/10.1038\/NCOMMS8131","journal-title":"Nat Commun"},{"key":"1368_CR7","doi-asserted-by":"publisher","first-page":"481108","DOI":"10.3389\/fnins.2019.01026","volume":"13","author":"Z Bai","year":"2019","unstructured":"Bai Z, Chen D, Wang L et al (2019) Cerebrospinal fluid and blood cytokines as biomarkers for multiple sclerosis: a systematic review and meta-analysis of 226 studies with 13,526 multiple sclerosis patients. Front Neurosci 13:481108. https:\/\/doi.org\/10.3389\/fnins.2019.01026","journal-title":"Front Neurosci"},{"key":"1368_CR8","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/78682","volume":"6","author":"F Bard","year":"2000","unstructured":"Bard F, Cannon C, Barbour R et al (2000) Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6:916\u2013919. https:\/\/doi.org\/10.1038\/78682","journal-title":"Nat Med"},{"key":"1368_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/JAD-160565","volume":"56","author":"M Boada","year":"2017","unstructured":"Boada M, Anaya F, Ortiz P et al (2017) Efficacy and safety of plasma exchange with 5% albumin to modify cerebrospinal fluid and plasma amyloid-\u03b2 concentrations and cognition outcomes in alzheimer\u2019s disease patients: a multicenter, randomized, controlled clinical trial. J Alzheimer\u2019s Dis 56:129\u2013143. https:\/\/doi.org\/10.3233\/JAD-160565","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1368_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/J.TRCI.2019.01.001","volume":"5","author":"M Boada","year":"2019","unstructured":"Boada M, L\u00f3pez O, N\u00fa\u00f1ez L et al (2019) Plasma exchange for Alzheimer\u2019s disease Management by Albumin Replacement (AMBAR) trial: study design and progress. Alzheimers Dement (N Y) 5:61\u201369. https:\/\/doi.org\/10.1016\/J.TRCI.2019.01.001","journal-title":"Alzheimers Dement (N Y)"},{"key":"1368_CR11","doi-asserted-by":"publisher","unstructured":"Bobati SS, Naik KR (2017) Therapeutic plasma exchange - an emerging treatment modality in patients with neurologic and non-neurologic diseases. J Clin Diagn Res 11:EC35\u2013EC37. https:\/\/doi.org\/10.7860\/JCDR\/2017\/27073.10480","DOI":"10.7860\/JCDR\/2017\/27073.10480"},{"key":"1368_CR12","doi-asserted-by":"publisher","unstructured":"Bochner DN, Sapp RW, Adelson JD,et al (2014) Blocking PirB up-regulates spines and functional synapses to unlock visual cortical plasticity and facilitate recovery from amblyopia. Sci Transl Med 6:258ra140. https:\/\/doi.org\/10.1126\/SCITRANSLMED.3010157","DOI":"10.1126\/SCITRANSLMED.3010157"},{"key":"1368_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/J.STEROIDS.2007.02.003","volume":"72","author":"DW Brann","year":"2007","unstructured":"Brann DW, Dhandapani K, Wakade C et al (2007) Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids 72:381\u2013405. https:\/\/doi.org\/10.1016\/J.STEROIDS.2007.02.003","journal-title":"Steroids"},{"key":"1368_CR14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1586\/14737175.2015.1028369","volume":"15","author":"A Burgess","year":"2015","unstructured":"Burgess A, Shah K, Hough O, Hynynen K (2015) Focused ultrasound-mediated drug delivery through the blood-brain barrier. Expert Rev Neurother 15:477\u2013491. https:\/\/doi.org\/10.1586\/14737175.2015.1028369","journal-title":"Expert Rev Neurother"},{"key":"1368_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17460441.2019.1667329","volume":"15","author":"R Cacabelos","year":"2020","unstructured":"Cacabelos R (2020) How plausible is an Alzheimer\u2019s disease vaccine? Expert Opin Drug Discov 15:1\u20136. https:\/\/doi.org\/10.1080\/17460441.2019.1667329","journal-title":"Expert Opin Drug Discov"},{"key":"1368_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000492573","volume":"65","author":"JM Castellano","year":"2019","unstructured":"Castellano JM (2019) Blood-based therapies to combat aging. Gerontology 65:84\u201389. https:\/\/doi.org\/10.1159\/000492573","journal-title":"Gerontology"},{"key":"1368_CR17","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1001\/JAMANEUROL.2015.1616","volume":"72","author":"JM Castellano","year":"2015","unstructured":"Castellano JM, Kirby ED, Wyss-Coray T (2015) Blood-borne revitalization of the aged brain. JAMA Neurol 72:1191\u20131194. https:\/\/doi.org\/10.1001\/JAMANEUROL.2015.1616","journal-title":"JAMA Neurol"},{"key":"1368_CR18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/NATURE22067","volume":"544","author":"JM Castellano","year":"2017","unstructured":"Castellano JM, Mosher KI, Abbey RJ et al (2017) Human umbilical cord plasma proteins revitalize hippocampal function in aged mice. Nature 544:488\u2013492. https:\/\/doi.org\/10.1038\/NATURE22067","journal-title":"Nature"},{"key":"1368_CR19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JPD-191683","volume":"9","author":"S Cerri","year":"2019","unstructured":"Cerri S, Mus L, Blandini F (2019) Parkinson\u2019s Disease in women and men: What\u2019s the difference? J Parkinsons Dis 9:501\u2013515. https:\/\/doi.org\/10.3233\/JPD-191683","journal-title":"J Parkinsons Dis"},{"key":"1368_CR20","doi-asserted-by":"publisher","unstructured":"CH van D, CJ S, P A, et al (2023) Lecanemab in early Alzheimer\u2019s Disease. N Engl J Med 388:142\u2013143.https:\/\/doi.org\/10.1056\/NEJMOA2212948","DOI":"10.1056\/NEJMOA2212948"},{"key":"1368_CR21","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/JNR.24829","volume":"99","author":"MJ Chen","year":"2021","unstructured":"Chen MJ, Ramesha S, Weinstock LD et al (2021) Extracellular signal-regulated kinase regulates microglial immune responses in Alzheimer\u2019s disease. J Neurosci Res 99:1704\u20131721. https:\/\/doi.org\/10.1002\/JNR.24829","journal-title":"J Neurosci Res"},{"key":"1368_CR22","doi-asserted-by":"publisher","first-page":"502","DOI":"10.4161\/MABS.27765","volume":"6","author":"N Chen","year":"2014","unstructured":"Chen N, Wang W, Fauty S et al (2014) The effect of the neonatal Fc receptor on human IgG biodistribution in mice. Mabs 6:502\u2013508. https:\/\/doi.org\/10.4161\/MABS.27765","journal-title":"Mabs"},{"key":"1368_CR23","first-page":"21","volume":"31","author":"R Chen","year":"2000","unstructured":"Chen R, Ende N (2000) The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. J Med 31:21\u201330","journal-title":"J Med"},{"key":"1368_CR24","doi-asserted-by":"publisher","unstructured":"Cohen S, Cummings J, Knox S et al (2022) Clinical trial endpoints and their clinical meaningfulness in early stages of Alzheimer\u2019s Disease. J Prev Alzheimers Dis 9:507. https:\/\/doi.org\/10.14283\/JPAD.2022.41","DOI":"10.14283\/JPAD.2022.41"},{"key":"1368_CR25","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1152\/AJPLEGACY.1969.217.5.1298","volume":"217","author":"DL Coleman","year":"1969","unstructured":"Coleman DL, Hummel KP (1969) Effects of parabiosis of normal with genetically diabetic mice. Am J Physiol 217:1298\u20131304. https:\/\/doi.org\/10.1152\/AJPLEGACY.1969.217.5.1298","journal-title":"Am J Physiol"},{"key":"1368_CR26","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/NATURE03260","volume":"433","author":"IM Conboy","year":"2005","unstructured":"Conboy IM, Conboy MJ, Wagers AJ et al (2005) Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433:760\u2013764. https:\/\/doi.org\/10.1038\/NATURE03260","journal-title":"Nature"},{"key":"1368_CR27","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/ACEL.12065","volume":"12","author":"MJ Conboy","year":"2013","unstructured":"Conboy MJ, Conboy IM, Rando TA (2013) Heterochronic parabiosis: historical perspective and methodological considerations for studies of aging and longevity. Aging Cell 12:525\u2013530. https:\/\/doi.org\/10.1111\/ACEL.12065","journal-title":"Aging Cell"},{"key":"1368_CR28","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1515\/MED-2017-0053","volume":"12","author":"M Conese","year":"2017","unstructured":"Conese M, Carbone A, Beccia E, Angiolillo A (2017) The fountain of youth: a tale of parabiosis, stem cells, and rejuvenation. Open Medicine 12:376\u2013383. https:\/\/doi.org\/10.1515\/MED-2017-0053","journal-title":"Open Medicine"},{"key":"1368_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/J.BRAINRES.2013.08.035","volume":"1534","author":"PR Cooper","year":"2013","unstructured":"Cooper PR, Ciambrone GJ, Kliwinski CM et al (2013) Efflux of monoclonal antibodies from rat brain by neonatal Fc receptor, FcRn. Brain Res 1534:13\u201321. https:\/\/doi.org\/10.1016\/J.BRAINRES.2013.08.035","journal-title":"Brain Res"},{"key":"1368_CR30","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2174\/1567205011666140812114037","volume":"11","author":"SE Counts","year":"2014","unstructured":"Counts SE, Perez SE, He B, Mufson EJ (2014a) Intravenous immunoglobulin reduces Tau pathology and preserves neuroplastic gene expression in the 3xTg mouse model of Alzheimer\u2019s Disease. Curr Alzheimer Res 11:655\u2013663. https:\/\/doi.org\/10.2174\/1567205011666140812114037","journal-title":"Curr Alzheimer Res"},{"key":"1368_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/S10875-014-0020-9","volume":"34","author":"SE Counts","year":"2014","unstructured":"Counts SE, Ray B, Mufson EJ et al (2014b) Intravenous Immunoglobulin (IVIG) treatment exerts antioxidant and neuropreservatory effects in preclinical models of Alzheimer\u2019s disease. J Clin Immunol 34:80\u201385. https:\/\/doi.org\/10.1007\/S10875-014-0020-9","journal-title":"J Clin Immunol"},{"key":"1368_CR32","doi-asserted-by":"publisher","unstructured":"Cummings J, Apostolova L, Rabinovici GD et al (2023) Lecanemab: appropriate use recommendations. J Prev Alzheimers Dis 10:362\u2013377. https:\/\/doi.org\/10.14283\/JPAD.2023.30","DOI":"10.14283\/JPAD.2023.30"},{"key":"1368_CR33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1089\/SCD.2012.0345","volume":"22","author":"D Darlington","year":"2013","unstructured":"Darlington D, Deng J, Giunta B et al (2013) Multiple low-dose infusions of human umbilical cord blood cells improve cognitive impairments and reduce amyloid-\u03b2-associated neuropathology in Alzheimer mice. Stem Cells Dev 22:412\u2013421. https:\/\/doi.org\/10.1089\/SCD.2012.0345","journal-title":"Stem Cells Dev"},{"key":"1368_CR34","doi-asserted-by":"publisher","first-page":"11495","DOI":"10.1523\/JNEUROSCI.3697-05.2005","volume":"25","author":"R Deane","year":"2005","unstructured":"Deane R, Sagare A, Hamm K et al (2005) IgG-assisted age-dependent clearance of Alzheimer\u2019s amyloid \u03b2 peptide by the blood-brain barrier neonatal Fc receptor. J Neurosci 25:11495\u201311503. https:\/\/doi.org\/10.1523\/JNEUROSCI.3697-05.2005","journal-title":"J Neurosci"},{"key":"1368_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/JME.20.1.31","volume":"20","author":"PR Del Pozo","year":"1994","unstructured":"Del Pozo PR (1994) Paying donors and the ethics of blood supply. J Med Ethics 20:31\u201335. https:\/\/doi.org\/10.1136\/JME.20.1.31","journal-title":"J Med Ethics"},{"key":"1368_CR36","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/JNC.13351","volume":"135","author":"J Deng","year":"2015","unstructured":"Deng J, Habib A, Obregon DF et al (2015) Soluble amyloid precursor protein alpha (sAPP\u03b1) inhibits tau phosphorylation through modulation of GSK3\u03b2 signaling pathway. J Neurochem 135:630\u2013637. https:\/\/doi.org\/10.1111\/JNC.13351","journal-title":"J Neurochem"},{"key":"1368_CR37","doi-asserted-by":"publisher","first-page":"952161","DOI":"10.3389\/fpubh.2022.952161","volume":"10","author":"C Ding","year":"2022","unstructured":"Ding C, Wu Y, Chen X et al (2022) Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990\u20132019. Front Public Health 10:952161. https:\/\/doi.org\/10.3389\/fpubh.2022.952161","journal-title":"Front Public Health"},{"key":"1368_CR38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ANA.10253","volume":"52","author":"R Dodel","year":"2002","unstructured":"Dodel R, Hampel H, Depboylu C et al (2002) Human antibodies against amyloid \u03b2 peptide: a potential treatment for Alzheimer\u2019s disease. Ann Neurol 52:253\u2013256. https:\/\/doi.org\/10.1002\/ANA.10253","journal-title":"Ann Neurol"},{"key":"1368_CR39","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1474-4422(13)70014-0","volume":"12","author":"R Dodel","year":"2013","unstructured":"Dodel R, Rominger A, Bartenstein P et al (2013) Intravenous immunoglobulins for the treatment of mild to moderate Alzheimer\u2019s disease: a phase II, randomised, double-blind, placebo-controlled dose-finding trial. Lancet Neurol 12:233\u2013243. https:\/\/doi.org\/10.1016\/S1474-4422(13)70014-0","journal-title":"Lancet Neurol"},{"key":"1368_CR40","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1136\/JNNP.2003.033399","volume":"75","author":"RC Dodel","year":"2004","unstructured":"Dodel RC, Du Y, Depboylu C et al (2004) Intravenous immunoglobulins containing antibodies against \u00df-amyloid for the treatment of Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 75:1472\u20131474. https:\/\/doi.org\/10.1136\/JNNP.2003.033399","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1368_CR41","doi-asserted-by":"publisher","first-page":"e12330","DOI":"10.1002\/TRC2.12330","volume":"8","author":"NV Dokholyan","year":"2022","unstructured":"Dokholyan NV, Mohs RC, Bateman RJ (2022) Challenges and progress in research, diagnostics, and therapeutics in Alzheimer\u2019s disease and related dementias. Alzheimer\u2019s Dement 8:e12330. https:\/\/doi.org\/10.1002\/TRC2.12330","journal-title":"Alzheimer\u2019s Dement"},{"key":"1368_CR42","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/J.1525-139X.2009.00584.X","volume":"22","author":"TB Dr\u00fceke","year":"2009","unstructured":"Dr\u00fceke TB, Massy ZA (2009) Beta2-microglobulin. Semin Dial 22:378\u2013380. https:\/\/doi.org\/10.1111\/J.1525-139X.2009.00584.X","journal-title":"Semin Dial"},{"key":"1368_CR43","doi-asserted-by":"publisher","first-page":"32691","DOI":"10.1073\/pnas.1908658117","volume":"117","author":"S Dubey","year":"2020","unstructured":"Dubey S, Heinen S, Krantic S et al (2020) Clinically approved IVIg delivered to the hippocampus with focused ultrasound promotes neurogenesis in a model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 117:32691\u201332700. https:\/\/doi.org\/10.1073\/pnas.1908658117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1368_CR44","doi-asserted-by":"publisher","first-page":"e002296","DOI":"10.1136\/JITC-2020-002296","volume":"9","author":"J Duerinck","year":"2021","unstructured":"Duerinck J, Schwarze JK, Awada G et al (2021) Original research: Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial. J Immunother Cancer 9:e002296. https:\/\/doi.org\/10.1136\/JITC-2020-002296","journal-title":"J Immunother Cancer"},{"key":"1368_CR45","doi-asserted-by":"publisher","first-page":"a028035","DOI":"10.1101\/CSHPERSPECT.A028035","volume":"9","author":"BN Dugger","year":"2017","unstructured":"Dugger BN, Dickson DW (2017) Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol 9:a028035. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A028035","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1368_CR46","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1001\/JAMAINTERNMED.2021.4607","volume":"181","author":"B Dunn","year":"2021","unstructured":"Dunn B, Stein P, Cavazzoni P (2021) Approval of aducanumab for Alzheimer Disease-The FDA\u2019s perspective. JAMA Intern Med 181:1277\u20131278. https:\/\/doi.org\/10.1001\/JAMAINTERNMED.2021.4607","journal-title":"JAMA Intern Med"},{"key":"1368_CR47","doi-asserted-by":"publisher","first-page":"835","DOI":"10.5604\/12321966.1129943","volume":"21","author":"M Dziechcia\u017c","year":"2014","unstructured":"Dziechcia\u017c M, Filip R (2014) Biological psychological and social determinants of old age: bio-psycho-social aspects of human aging. Ann Agric Environ Med 21:835\u2013838. https:\/\/doi.org\/10.5604\/12321966.1129943","journal-title":"Ann Agric Environ Med"},{"key":"1368_CR48","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/J.CMET.2015.05.010","volume":"22","author":"MA Egerman","year":"2015","unstructured":"Egerman MA, Cadena SM, Gilbert JA et al (2015) GDF11 increases with age and inhibits skeletal muscle regeneration. Cell Metab 22:164\u2013174. https:\/\/doi.org\/10.1016\/J.CMET.2015.05.010","journal-title":"Cell Metab"},{"key":"1368_CR49","doi-asserted-by":"publisher","first-page":"w13914","DOI":"10.4414\/SMW.2014.13914","volume":"144","author":"A Eggel","year":"2014","unstructured":"Eggel A, Wyss-Coray T (2014) Parabiosis for the study of age-related chronic disease. Swiss Med Wkly 144:w13914. https:\/\/doi.org\/10.4414\/SMW.2014.13914","journal-title":"Swiss Med Wkly"},{"key":"1368_CR50","first-page":"231","volume":"32","author":"N Ende","year":"2001","unstructured":"Ende N, Chen R (2001) Human umbilical cord blood cells ameliorate Huntington\u2019s disease in transgenic mice. J Med 32:231\u2013240","journal-title":"J Med"},{"key":"1368_CR51","first-page":"173","volume":"33","author":"N Ende","year":"2002","unstructured":"Ende N, Chen R (2002) Parkinson\u2019s disease mice and human umbilical cord blood. J Med 33:173\u2013180","journal-title":"J Med"},{"key":"1368_CR52","first-page":"241","volume":"32","author":"N Ende","year":"2001","unstructured":"Ende N, Chen R, Ende-Harris D (2001) Human umbilical cord blood cells ameliorate Alzheimer\u2019s disease in transgenic mice. J Med 32:241\u2013247","journal-title":"J Med"},{"key":"1368_CR53","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1124\/JPET.114.213074","volume":"349","author":"MA Erickson","year":"2014","unstructured":"Erickson MA, Morofuji Y, Owen JB, Banks WA (2014) Rapid transport of CCL11 across the blood-brain barrier: regional variation and importance of blood cells. J Pharmacol Exp Ther 349:497\u2013507. https:\/\/doi.org\/10.1124\/JPET.114.213074","journal-title":"J Pharmacol Exp Ther"},{"key":"1368_CR54","doi-asserted-by":"publisher","unstructured":"Fei Z, Pan B, Pei R et al (2023) Neuroprotective Effects of IVIG against Alzheimer\u2019s Disease via regulation of antigen processing and presentation by MHC Class I molecules in 3xTg-AD mice. J Prev Alzheimer\u2019s Dis 10:581\u2013594. https:\/\/doi.org\/10.14283\/jpad.2023.56","DOI":"10.14283\/jpad.2023.56"},{"key":"1368_CR55","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/S13643-022-02115-Y","volume":"11","author":"Z Fei","year":"2022","unstructured":"Fei Z, Pan B, Pei R et al (2022) Efficacy and safety of blood derivatives therapy in Alzheimer\u2019s disease: a systematic review and meta-analysis. Syst Rev 11:256. https:\/\/doi.org\/10.1186\/S13643-022-02115-Y","journal-title":"Syst Rev"},{"key":"1368_CR56","doi-asserted-by":"publisher","unstructured":"Ferreira AC, Hemmer BM, Philippi SM et al (2023) Neuronal TIMP2 regulates hippocampus-dependent plasticity and extracellular matrix complexity. bioRxiv 522138. https:\/\/doi.org\/10.1101\/2022.12.28.522138","DOI":"10.1101\/2022.12.28.522138"},{"key":"1368_CR57","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/NM.3926","volume":"21","author":"AJ Filiano","year":"2015","unstructured":"Filiano AJ, Kipnis J (2015) Breaking bad blood: \u03b22-microglobulin as a pro-aging factor in blood. Nat Med 21:844\u2013845. https:\/\/doi.org\/10.1038\/NM.3926","journal-title":"Nat Med"},{"key":"1368_CR58","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1212\/NXI.0000000000000138","volume":"2","author":"T Furukawa","year":"2015","unstructured":"Furukawa T, Matsui N, Fujita K et al (2015) CSF cytokine profile distinguishes multifocal motor neuropathy from progressive muscular atrophy. Neurol - Neuroimmunol Neuroinflammation 2:e138. https:\/\/doi.org\/10.1212\/NXI.0000000000000138","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"key":"1368_CR59","doi-asserted-by":"publisher","first-page":"12524","DOI":"10.1073\/pnas.1902672116","volume":"116","author":"KJ Gan","year":"2019","unstructured":"Gan KJ, S\u00fcdhof TC (2019) Specific factors in blood from young but not old mice directly promote synapse formation and NMDA-receptor recruitment. Proc Natl Acad Sci U S A 116:12524\u201312533. https:\/\/doi.org\/10.1073\/pnas.1902672116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1368_CR60","doi-asserted-by":"publisher","unstructured":"Gandhi KR, Saadabadi A (2023) Levodopa (L-Dopa). PNDR: psychologists\u2019 neuropsychotropic drug reference 185\u2013189. https:\/\/doi.org\/10.4324\/9781315825748-35","DOI":"10.4324\/9781315825748-35"},{"key":"1368_CR61","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.cell.2023.01.021","volume":"186","author":"Y Gao","year":"2023","unstructured":"Gao Y, Hong Y, Huang L et al (2023) \u03b22-microglobulin functions as an endogenous NMDAR antagonist to impair synaptic function. Cell 186:1026-1038.e20. https:\/\/doi.org\/10.1016\/j.cell.2023.01.021","journal-title":"Cell"},{"key":"1368_CR62","unstructured":"Gauthier S, Webster C, Servaes S et al (2022) World Alzheimer Report 2022: life after diagnosis: navigating treatment, care and support. London"},{"key":"1368_CR63","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/NM850","volume":"9","author":"SS Gill","year":"2003","unstructured":"Gill SS, Patel NK, Hotton GR et al (2003) Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 9:589\u2013595. https:\/\/doi.org\/10.1038\/NM850","journal-title":"Nat Med"},{"key":"1368_CR64","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/J.MOLIMM.2013.06.016","volume":"56","author":"B Gong","year":"2013","unstructured":"Gong B, Pan Y, Zhao W et al (2013) IVIG immunotherapy protects against synaptic dysfunction in Alzheimer\u2019s disease through complement anaphylatoxin C5a-mediated AMPA-CREB-C\/EBP signaling pathway. Mol Immunol 56:619\u2013629. https:\/\/doi.org\/10.1016\/J.MOLIMM.2013.06.016","journal-title":"Mol Immunol"},{"key":"1368_CR65","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0011-393X(03)00059-6","volume":"64","author":"GT Grossberg","year":"2003","unstructured":"Grossberg GT (2003) Cholinesterase inhibitors for the treatment of Alzheimer\u2019s Disease: getting on and staying on. Curr Ther Res Clin Exp 64:216\u2013235. https:\/\/doi.org\/10.1016\/S0011-393X(03)00059-6","journal-title":"Curr Ther Res Clin Exp"},{"key":"1368_CR66","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1177\/0963689718759473","volume":"27","author":"A Habib","year":"2018","unstructured":"Habib A, Hou H, Mori T et al (2018) Human umbilical cord blood serum\u2013derived \u03b1-secretase: functional testing in Alzheimer\u2019s Disease Mouse models. Cell Transplant 27:438\u2013455. https:\/\/doi.org\/10.1177\/0963689718759473","journal-title":"Cell Transplant"},{"key":"1368_CR67","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/JNR.23823","volume":"95","author":"A Habib","year":"2017","unstructured":"Habib A, Sawmiller D, Tan J (2017) Restoring sAPP\u03b1 functions as a potential treatment for Alzheimer\u2019s disease. J Neurosci Res 95:973\u2013991. https:\/\/doi.org\/10.1002\/JNR.23823","journal-title":"J Neurosci Res"},{"key":"1368_CR68","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.3233\/JAD-210011","volume":"81","author":"J Hannestad","year":"2021","unstructured":"Hannestad J, Duclos T, Chao W et al (2021) Safety and tolerability of GRF6019 infusions in severe Alzheimer\u2019s Disease: a phase II double-blind placebo-controlled trial. J Alzheimers Dis 81:1649\u20131662. https:\/\/doi.org\/10.3233\/JAD-210011","journal-title":"J Alzheimers Dis"},{"key":"1368_CR69","doi-asserted-by":"publisher","first-page":"e12115","DOI":"10.1002\/TRC2.12115","volume":"6","author":"J Hannestad","year":"2020","unstructured":"Hannestad J, Koborsi K, Klutzaritz V et al (2020) Safety and tolerability of GRF6019 in mild-to-moderate Alzheimer\u2019s disease dementia. Alzheimers Dement (N Y) 6:e12115. https:\/\/doi.org\/10.1002\/TRC2.12115","journal-title":"Alzheimers Dement (N Y)"},{"key":"1368_CR70","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1073\/PNAS.0805453106","volume":"106","author":"CA Hawkes","year":"2009","unstructured":"Hawkes CA, McLaurin J (2009) Selective targeting of perivascular macrophages for clearance of \u03b2-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci U S A 106:1261\u20131266. https:\/\/doi.org\/10.1073\/PNAS.0805453106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1368_CR71","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3390\/BRAINSCI13060841","volume":"13","author":"CM Hernandez","year":"2023","unstructured":"Hernandez CM, Barkey RE, Craven KM et al (2023) Transfusion with blood plasma from young mice affects rTg4510 transgenic tau mice modeling of Alzheimer\u2019s disease. Brain Sci 13:841. https:\/\/doi.org\/10.3390\/BRAINSCI13060841","journal-title":"Brain Sci"},{"key":"1368_CR72","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/AGEING\/AFP223","volume":"39","author":"JV Hindle","year":"2010","unstructured":"Hindle JV (2010) Ageing, neurodegeneration and Parkinson\u2019s disease. Age Ageing 39:156\u2013161. https:\/\/doi.org\/10.1093\/AGEING\/AFP223","journal-title":"Age Ageing"},{"key":"1368_CR73","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000445751","volume":"46","author":"L Hirsch","year":"2016","unstructured":"Hirsch L, Jette N, Frolkis A et al (2016) The incidence of Parkinson\u2019s disease: a systematic review and meta-analysis. Neuroepidemiology 46:292\u2013300. https:\/\/doi.org\/10.1159\/000445751","journal-title":"Neuroepidemiology"},{"key":"1368_CR74","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000481828","volume":"45","author":"B Hofmann","year":"2018","unstructured":"Hofmann B (2018) Young blood rejuvenates old bodies: a call for reflection when moving from mice to men. Transfus Med Hemother 45:67\u201371. https:\/\/doi.org\/10.1159\/000481828","journal-title":"Transfus Med Hemother"},{"key":"1368_CR75","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/S41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y, Dan X, Babbar M et al (2019) Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 15:565\u2013581. https:\/\/doi.org\/10.1038\/S41582-019-0244-7","journal-title":"Nat Rev Neurol"},{"key":"1368_CR76","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1148\/RADIOL.2202001804","volume":"220","author":"K Hynynen","year":"2001","unstructured":"Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA (2001) Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 220:640\u2013646. https:\/\/doi.org\/10.1148\/RADIOL.2202001804","journal-title":"Radiology"},{"key":"1368_CR77","doi-asserted-by":"publisher","first-page":"e12004","DOI":"10.1002\/TRC2.12004","volume":"6","author":"BP Imbimbo","year":"2020","unstructured":"Imbimbo BP, Ippati S, Ceravolo F, Watling M (2020) Perspective: is therapeutic plasma exchange a viable option for treating Alzheimer\u2019s disease? Alzheimer\u2019s Dement 6:e12004. https:\/\/doi.org\/10.1002\/TRC2.12004","journal-title":"Alzheimer\u2019s Dement"},{"key":"1368_CR78","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/0310057X9302100110","volume":"21","author":"JP Isbister","year":"1993","unstructured":"Isbister JP (1993) Adverse reactions to plasma and plasma components. Anaesth Intensive Care 21:31\u201338. https:\/\/doi.org\/10.1177\/0310057X9302100110","journal-title":"Anaesth Intensive Care"},{"key":"1368_CR79","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/PH13090230","volume":"13","author":"M Ivanovska","year":"2020","unstructured":"Ivanovska M, Abdi Z, Murdjeva M et al (2020) CCL-11 or Eotaxin-1: an immune marker for ageing and accelerated ageing in neuro-psychiatric disorders. Pharmaceuticals (Basel) 13:230. https:\/\/doi.org\/10.3390\/PH13090230","journal-title":"Pharmaceuticals (Basel)"},{"key":"1368_CR80","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/S42255-022-00609-6","volume":"4","author":"OH Jeon","year":"2022","unstructured":"Jeon OH, Mehdipour M, Gil TH et al (2022) Systemic induction of senescence in young mice after single heterochronic blood exchange. Nat Metab 4:995\u20131006. https:\/\/doi.org\/10.1038\/S42255-022-00609-6","journal-title":"Nat Metab"},{"key":"1368_CR81","doi-asserted-by":"publisher","first-page":"e10549","DOI":"10.1371\/JOURNAL.PONE.0010549","volume":"5","author":"JF Jord\u00e3o","year":"2010","unstructured":"Jord\u00e3o JF, Ayala-Grosso CA, Markham K et al (2010) Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-\u03b2 plaque load in the TgCRND8 mouse model of Alzheimer\u2019s disease. PLoS One 5:e10549. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0010549","journal-title":"PLoS One"},{"key":"1368_CR82","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1006\/BBRC.1994.2734","volume":"205","author":"PJ Jose","year":"1994","unstructured":"Jose PJ, Adcock IM, Griffithsjohnson DA et al (1994) Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. Biochem Biophys Res Commun 205:788\u2013794. https:\/\/doi.org\/10.1006\/BBRC.1994.2734","journal-title":"Biochem Biophys Res Commun"},{"key":"1368_CR83","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s42003-020-0797-4","volume":"3","author":"S Kang","year":"2020","unstructured":"Kang S, Moser VA, Svendsen CN, Goodridge HS (2020) Rejuvenating the blood and bone marrow to slow aging-associated cognitive decline and Alzheimer\u2019s disease. Commun Biol 3:69. https:\/\/doi.org\/10.1038\/s42003-020-0797-4","journal-title":"Commun Biol"},{"key":"1368_CR84","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1126\/SCIENCE.1251141","volume":"344","author":"L Katsimpardi","year":"2014","unstructured":"Katsimpardi L, Litterman NK, Schein PA et al (2014) Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science 344:630\u2013634. https:\/\/doi.org\/10.1126\/SCIENCE.1251141","journal-title":"Science"},{"key":"1368_CR85","doi-asserted-by":"publisher","first-page":"624","DOI":"10.4103\/1673-5374.230277","volume":"13","author":"R Khoury","year":"2018","unstructured":"Khoury R, Ghossoub E (2018) Young blood products: emerging treatment for Alzheimer\u2019s disease? Neural Regen Res 13:624. https:\/\/doi.org\/10.4103\/1673-5374.230277","journal-title":"Neural Regen Res"},{"key":"1368_CR86","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1136\/JNNP-2015-311486","volume":"88","author":"S Kile","year":"2017","unstructured":"Kile S, Au W, Parise C et al (2017) IVIG treatment of mild cognitive impairment due to Alzheimer\u2019s disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia. J Neurol Neurosurg Psychiatry 88:106\u2013112. https:\/\/doi.org\/10.1136\/JNNP-2015-311486","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1368_CR87","doi-asserted-by":"publisher","unstructured":"Kim HJ, Cho KR, Jang H et al (2021) Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: a phase I clinical trial. Alzheimers Res Ther 13:. https:\/\/doi.org\/10.1186\/S13195-021-00897-2","DOI":"10.1186\/S13195-021-00897-2"},{"key":"1368_CR88","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/J.TRCI.2015.06.007","volume":"1","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Seo SW, Chang JW et al (2015) Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: A phase 1 clinical trial. Alzheimers Dement (N Y) 1:95\u2013102. https:\/\/doi.org\/10.1016\/J.TRCI.2015.06.007","journal-title":"Alzheimers Dement (N Y)"},{"key":"1368_CR89","doi-asserted-by":"publisher","unstructured":"Klein A (2019) Young blood tested on Parkinson\u2019s. New Sci (1956) 241:6. https:\/\/doi.org\/10.1016\/S0262-4079(19)30003-X","DOI":"10.1016\/S0262-4079(19)30003-X"},{"key":"1368_CR90","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1084\/JEM.130.6.1353","volume":"130","author":"KD Knudsen","year":"1969","unstructured":"Knudsen KD, Iwai J, Heine M et al (1969) Genetic influence on the development of renoprival hypertension in parabiotic rats. Evidence that a humoral hypertensinogenic factor is produced in kidney tissue of hypertension-prone rats. J Exp Med 130:1353\u20131365. https:\/\/doi.org\/10.1084\/JEM.130.6.1353","journal-title":"J Exp Med"},{"key":"1368_CR91","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/S41746-019-0084-2","volume":"2","author":"LC Kourtis","year":"2019","unstructured":"Kourtis LC, Regele OB, Wright JM, Jones GB (2019) Digital biomarkers for Alzheimer\u2019s disease: the mobile\/wearable devices opportunity. NPJ Digit Med 2:9. https:\/\/doi.org\/10.1038\/S41746-019-0084-2","journal-title":"NPJ Digit Med"},{"key":"1368_CR92","doi-asserted-by":"publisher","unstructured":"Kovacs GG (2014) Current Concepts of Neurodegenerative Diseases. EMJ Neurol Neurology 1:10\u201311. https:\/\/doi.org\/10.33590\/EMJNEUROL\/10314777","DOI":"10.33590\/EMJNEUROL\/10314777"},{"key":"1368_CR93","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/IJMS17020189","volume":"17","author":"GG Kovacs","year":"2016","unstructured":"Kovacs GG (2016) Molecular pathological classification of neurodegenerative diseases: turning towards precision medicine. Int J Mol Sci 17:189. https:\/\/doi.org\/10.3390\/IJMS17020189","journal-title":"Int J Mol Sci"},{"key":"1368_CR94","doi-asserted-by":"publisher","first-page":"P800","DOI":"10.1016\/J.JALZ.2013.05.1650","volume":"9","author":"D Lahiri","year":"2013","unstructured":"Lahiri D, Ray B, Fiala M et al (2013) P4\u2013257: effect of IVIg in preserving human primary neurons and protecting them against oxidative stress. Alzheimer\u2019s Dement 9:P800\u2013P800. https:\/\/doi.org\/10.1016\/J.JALZ.2013.05.1650","journal-title":"Alzheimer\u2019s Dement"},{"key":"1368_CR95","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/mp.2015.131","volume":"20","author":"MA Lalli","year":"2015","unstructured":"Lalli MA, Bettcher BM, Arcila ML et al (2015) Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer\u2019s disease. Mol Psychiatry 20:1294\u20131300. https:\/\/doi.org\/10.1038\/mp.2015.131","journal-title":"Mol Psychiatry"},{"key":"1368_CR96","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/IJMS23031851","volume":"23","author":"RNL Lamptey","year":"2022","unstructured":"Lamptey RNL, Chaulagain B, Trivedi R et al (2022) A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics. Int J Mol Sci 23:1851. https:\/\/doi.org\/10.3390\/IJMS23031851","journal-title":"Int J Mol Sci"},{"key":"1368_CR97","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/S11019-020-09952-5","volume":"23","author":"A Lavazza","year":"2020","unstructured":"Lavazza A, Garasic M (2020) Vampires 2.0? The ethical quandaries of young blood infusion in the quest for eternal life. Med Health Care Philos 23:421\u2013432. https:\/\/doi.org\/10.1007\/S11019-020-09952-5","journal-title":"Med Health Care Philos"},{"key":"1368_CR98","doi-asserted-by":"publisher","first-page":"26199","DOI":"10.1038\/srep26199","volume":"6","author":"MJ Lazarczyk","year":"2016","unstructured":"Lazarczyk MJ, Kemmler JE, Eyford BA et al (2016) Major Histocompatibility Complex class I proteins are critical for maintaining neuronal structural complexity in the aging brain. Sci Rep 6:26199. https:\/\/doi.org\/10.1038\/srep26199","journal-title":"Sci Rep"},{"key":"1368_CR99","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/ART.41230","volume":"72","author":"L Li","year":"2020","unstructured":"Li L, Wei X, Wang D et al (2020) Positive effects of a young systemic environment and high growth differentiation factor 11 levels on chondrocyte proliferation and cartilage matrix synthesis in old mice. Arthritis Rheumatol 72:1123\u20131133. https:\/\/doi.org\/10.1002\/ART.41230","journal-title":"Arthritis Rheumatol"},{"key":"1368_CR100","doi-asserted-by":"publisher","unstructured":"Liu B, Cheng W, Cheng D et al (2021a) PirB functions as an intrinsic suppressor in hippocampal neural stem cells. Aging 13:16062\u201316071. https:\/\/doi.org\/10.18632\/AGING.203134","DOI":"10.18632\/AGING.203134"},{"key":"1368_CR101","doi-asserted-by":"publisher","unstructured":"Liu X, Maria NSS, Lin SW, Jacobs RE (2021b) The Applications of Focused Ultrasound (FUS) in Alzheimer\u2019s disease treatment: a systematic review on both animal and human studies. Aging Dis 12:1977\u20132002. https:\/\/doi.org\/10.14336\/AD.2021.0510","DOI":"10.14336\/AD.2021.0510"},{"key":"1368_CR102","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/J.ADDR.2011.11.002","volume":"64","author":"JJ Lochhead","year":"2012","unstructured":"Lochhead JJ, Thorne RG (2012) Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev 64:614\u2013628. https:\/\/doi.org\/10.1016\/J.ADDR.2011.11.002","journal-title":"Adv Drug Deliv Rev"},{"key":"1368_CR103","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3389\/FNEUR.2020.00459","volume":"11","author":"DA Loeffler","year":"2020","unstructured":"Loeffler DA (2020) AMBAR, an encouraging Alzheimer\u2019s trial that raises questions. Front Neurol 11:459. https:\/\/doi.org\/10.3389\/FNEUR.2020.00459","journal-title":"Front Neurol"},{"key":"1368_CR104","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1186\/1742-2094-10-70","volume":"10","author":"DA Loeffler","year":"2013","unstructured":"Loeffler DA (2013) Intravenous immunoglobulin and Alzheimer\u2019s disease: What now? J Neuroinflammation 10:853. https:\/\/doi.org\/10.1186\/1742-2094-10-70","journal-title":"J Neuroinflammation"},{"key":"1368_CR105","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/J.CELL.2013.04.015","volume":"153","author":"FS Loffredo","year":"2013","unstructured":"Loffredo FS, Steinhauser ML, Jay SM et al (2013) Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell 153:828. https:\/\/doi.org\/10.1016\/J.CELL.2013.04.015","journal-title":"Cell"},{"key":"1368_CR106","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/J.CELL.2013.05.039","volume":"153","author":"C L\u00f3pez-Ot\u00edn","year":"2013","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L et al (2013) The hallmarks of aging. Cell 153:1194\u20131217. https:\/\/doi.org\/10.1016\/J.CELL.2013.05.039","journal-title":"Cell"},{"key":"1368_CR107","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1742-2094-7-90","volume":"7","author":"J Magga","year":"2010","unstructured":"Magga J, Puli L, Pihlaja R et al (2010) Human intravenous immunoglobulin provides protection against A\u03b2 toxicity by multiple mechanisms in a mouse model of Alzheimer\u2019s disease. J Neuroinflammation 7:90. https:\/\/doi.org\/10.1186\/1742-2094-7-90","journal-title":"J Neuroinflammation"},{"key":"1368_CR108","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/0024-3205(94)00331-9","volume":"55","author":"LM Maness","year":"1994","unstructured":"Maness LM, Banks WA, Podlisny MB et al (1994) Passage of human amyloid beta-protein 1\u201340 across the murine blood-brain barrier. Life Sci 55:1643\u20131650. https:\/\/doi.org\/10.1016\/0024-3205(94)00331-9","journal-title":"Life Sci"},{"key":"1368_CR109","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/1533317519843720","volume":"34","author":"A Manolopoulos","year":"2019","unstructured":"Manolopoulos A, Andreadis P, Malandris K et al (2019) Intravenous immunoglobulin for patients with Alzheimer\u2019s disease: a systematic review and meta-analysis. Am J Alzheimers Dis Other Demen 34:281\u2013289. https:\/\/doi.org\/10.1177\/1533317519843720","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"1368_CR110","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/BIT.26967","volume":"116","author":"JL Mantle","year":"2019","unstructured":"Mantle JL, Lee KH (2019) Immunoglobulin G transport increases in an in vitro blood-brain barrier model with amyloid-\u03b2 and with neuroinflammatory cytokines. Biotechnol Bioeng 116:1752\u20131761. https:\/\/doi.org\/10.1002\/BIT.26967","journal-title":"Biotechnol Bioeng"},{"key":"1368_CR111","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13041-021-00845-z","volume":"14","author":"BA Mayweather","year":"2021","unstructured":"Mayweather BA, Buchanan SM, Rubin LL (2021) GDF11 expressed in the adult brain negatively regulates hippocampal neurogenesis. Mol Brain 14:134. https:\/\/doi.org\/10.1186\/s13041-021-00845-z","journal-title":"Mol Brain"},{"key":"1368_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11357-020-00297-8","volume":"43","author":"M Mehdipour","year":"2021","unstructured":"Mehdipour M, Mehdipour T, Skinner CM et al (2021) Plasma dilution improves cognition and attenuates neuroinflammation in old mice. Geroscience 43:1\u201318. https:\/\/doi.org\/10.1007\/S11357-020-00297-8","journal-title":"Geroscience"},{"key":"1368_CR113","doi-asserted-by":"publisher","unstructured":"Mehdipour M, Skinner C, Wong N et al (2020) Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin. Aging (Albany NY) 12:8790\u20138819. https:\/\/doi.org\/10.18632\/AGING.103418","DOI":"10.18632\/AGING.103418"},{"key":"1368_CR114","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/J.CELREP.2013.10.010","volume":"5","author":"JP Michaud","year":"2013","unstructured":"Michaud JP, Bellavance MA, Pr\u00e9fontaine P, Rivest S (2013) Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta. Cell Rep 5:646\u2013653. https:\/\/doi.org\/10.1016\/J.CELREP.2013.10.010","journal-title":"Cell Rep"},{"key":"1368_CR115","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1001\/JAMANEUROL.2016.3185","volume":"73","author":"J Middeldorp","year":"2016","unstructured":"Middeldorp J, Lehallier B, Villeda SA et al (2016) Preclinical assessment of young blood plasma for Alzheimer disease. JAMA Neurol 73:1325\u20131333. https:\/\/doi.org\/10.1001\/JAMANEUROL.2016.3185","journal-title":"JAMA Neurol"},{"key":"1368_CR116","doi-asserted-by":"publisher","unstructured":"Myeong SH, Kim H, Lee NK et al (2022) Intracerebroventricular administration of human umbilical cord blood-derived mesenchymal stem cells induces transient inflammation in a transgenic mouse model and patients with Alzheimer\u2019s disease. Biomedicines 10:. https:\/\/doi.org\/10.3390\/BIOMEDICINES10030563","DOI":"10.3390\/BIOMEDICINES10030563"},{"key":"1368_CR117","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/CNE.901850307","volume":"185","author":"Z Nagy","year":"1979","unstructured":"Nagy Z, Pappius HM, Mathieson G, H\u00fcttner I (1979) Opening of tight junctions in cerebral endothelium. I. Effect of hyperosmolar mannitol infused through the internal carotid artery. J Comp Neurol 185:569\u2013578. https:\/\/doi.org\/10.1002\/CNE.901850307","journal-title":"J Comp Neurol"},{"key":"1368_CR118","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3727\/000000007783464623","volume":"16","author":"JD Newcomb","year":"2007","unstructured":"Newcomb JD, Sanberg PR, Klasko SK, Willing AE (2007) Umbilical cord blood research: current and future perspectives. Cell Transplant 16:151\u2013158. https:\/\/doi.org\/10.3727\/000000007783464623","journal-title":"Cell Transplant"},{"key":"1368_CR119","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/BF03033155","volume":"5","author":"MB Newman","year":"2003","unstructured":"Newman MB, Davis CD, Kuzmin-Nichols N, Sanberg PR (2003) Human Umbilical Cord Blood (HUCB) cells for central nervous system repair. Neurotox Res 5:355\u2013368. https:\/\/doi.org\/10.1007\/BF03033155","journal-title":"Neurotox Res"},{"key":"1368_CR120","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1089\/SCD.2008.0018","volume":"17","author":"WV Nikolic","year":"2008","unstructured":"Nikolic WV, Hou H, Town T et al (2008) Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular \u03b2-amyloid deposits in Alzheimer mice. Stem Cells Dev 17:423\u2013440. https:\/\/doi.org\/10.1089\/SCD.2008.0018","journal-title":"Stem Cells Dev"},{"key":"1368_CR121","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/ANNUREV.IMMUNOL.26.021607.090232","volume":"26","author":"F Nimmerjahn","year":"2008","unstructured":"Nimmerjahn F, Ravetch JV (2008) Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol 26:513\u2013533. https:\/\/doi.org\/10.1146\/ANNUREV.IMMUNOL.26.021607.090232","journal-title":"Annu Rev Immunol"},{"key":"1368_CR122","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/BRAIN\/AWX052","volume":"140","author":"RM Nisbet","year":"2017","unstructured":"Nisbet RM, Van Der Jeugd A, Leinenga G et al (2017) Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model. Brain 140:1220\u20131230. https:\/\/doi.org\/10.1093\/BRAIN\/AWX052","journal-title":"Brain"},{"key":"1368_CR123","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3109\/15622975.2015.1062552","volume":"16","author":"C Noto","year":"2015","unstructured":"Noto C, Maes M, Ota VK et al (2015) High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance. World J Biol Psychiatry 16:422\u2013429. https:\/\/doi.org\/10.3109\/15622975.2015.1062552","journal-title":"World J Biol Psychiatry"},{"key":"1368_CR124","doi-asserted-by":"publisher","first-page":"11076","DOI":"10.1073\/PNAS.0402970101","volume":"101","author":"RJ Ober","year":"2004","unstructured":"Ober RJ, Martinez C, Lai X et al (2004a) Exocytosis of IgG as mediated by the receptor, FcRn: an analysis at the single-molecule level. Proc Natl Acad Sci U S A 101:11076\u201311081. https:\/\/doi.org\/10.1073\/PNAS.0402970101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1368_CR125","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.4049\/JIMMUNOL.172.4.2021","volume":"172","author":"RJ Ober","year":"2004","unstructured":"Ober RJ, Martinez C, Vaccaro C et al (2004b) Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn. J Immunol 172:2021\u20132029. https:\/\/doi.org\/10.4049\/JIMMUNOL.172.4.2021","journal-title":"J Immunol"},{"key":"1368_CR126","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/INTIMM\/13.12.1551","volume":"13","author":"RJ Ober","year":"2001","unstructured":"Ober RJ, Radu CG, Ghetie V, Ward ES (2001) Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. Int Immunol 13:1551\u20131559. https:\/\/doi.org\/10.1093\/INTIMM\/13.12.1551","journal-title":"Int Immunol"},{"key":"1368_CR127","doi-asserted-by":"publisher","first-page":"e12110","DOI":"10.1002\/TRC2.12110","volume":"6","author":"AL Oblak","year":"2020","unstructured":"Oblak AL, Forner S, Territo PR et al (2020) Model organism development and evaluation for late-onset Alzheimer\u2019s disease: MODEL-AD. Alzheimers Dement (N Y) 6:e12110. https:\/\/doi.org\/10.1002\/TRC2.12110","journal-title":"Alzheimers Dement (N Y)"},{"key":"1368_CR128","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/NCOMMS1781","volume":"3","author":"D Obregon","year":"2012","unstructured":"Obregon D, Hou H, Deng J et al (2012) sAPP-\u03b1 modulates \u03b2-secretase activity and amyloid-\u03b2 generation. Nat Commun 3:777. https:\/\/doi.org\/10.1038\/NCOMMS1781","journal-title":"Nat Commun"},{"key":"1368_CR129","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3233\/JAD-180888","volume":"66","author":"M Okuya","year":"2018","unstructured":"Okuya M, Matsunaga S, Ikuta T et al (2018) Efficacy, acceptability, and safety of intravenous immunoglobulin administration for mild-to-moderate Alzheimer\u2019s disease: a systematic review and meta-analysis. J Alzheimers Dis 66:1379\u20131387. https:\/\/doi.org\/10.3233\/JAD-180888","journal-title":"J Alzheimers Dis"},{"key":"1368_CR130","doi-asserted-by":"publisher","first-page":"17293","DOI":"10.1038\/s41598-018-35716-6","volume":"8","author":"C Ozek","year":"2018","unstructured":"Ozek C, Krolewski RC, Buchanan SM, Rubin LL (2018) Growth differentiation factor 11 treatment leads to neuronal and vascular improvements in the hippocampus of aged mice. Sci Rep 8:17293. https:\/\/doi.org\/10.1038\/s41598-018-35716-6","journal-title":"Sci Rep"},{"key":"1368_CR131","doi-asserted-by":"publisher","unstructured":"Pandey S, Vyas GN (2012) Adverse effects of plasma transfusion. Transfusion (Paris) 52:65S.https:\/\/doi.org\/10.1111\/J.1537-2995.2012.03663.X","DOI":"10.1111\/J.1537-2995.2012.03663.X"},{"key":"1368_CR132","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1021\/ACSCENTSCI.9B00902","volume":"5","author":"M Pandika","year":"2019","unstructured":"Pandika M (2019) Looking to young blood to treat the diseases of aging. ACS Cent Sci 5:1481\u20131484. https:\/\/doi.org\/10.1021\/ACSCENTSCI.9B00902","journal-title":"ACS Cent Sci"},{"key":"1368_CR133","doi-asserted-by":"publisher","first-page":"100948","DOI":"10.1016\/J.ARR.2019.100948","volume":"55","author":"F Panza","year":"2019","unstructured":"Panza F, Lozupone M, Bellomo A, Pietro IB (2019a) Do anti-amyloid-\u03b2 drugs affect neuropsychiatric status in Alzheimer\u2019s disease patients? Ageing Res Rev 55:100948. https:\/\/doi.org\/10.1016\/J.ARR.2019.100948","journal-title":"Ageing Res Rev"},{"key":"1368_CR134","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ANA.25410","volume":"85","author":"F Panza","year":"2019","unstructured":"Panza F, Lozupone M, Seripa D, Imbimbo BP (2019b) Amyloid-\u03b2 immunotherapy for alzheimer disease: is it now a long shot? Ann Neurol 85:303\u2013315. https:\/\/doi.org\/10.1002\/ANA.25410","journal-title":"Ann Neurol"},{"key":"1368_CR135","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/B978-0-12-396962-0.00011-2","volume":"503","author":"WM Pardridge","year":"2012","unstructured":"Pardridge WM, Boado RJ (2012) Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier. Methods Enzymol 503:269\u2013292. https:\/\/doi.org\/10.1016\/B978-0-12-396962-0.00011-2","journal-title":"Methods Enzymol"},{"key":"1368_CR136","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/MDS.28198","volume":"35","author":"JE Parker","year":"2020","unstructured":"Parker JE, Martinez A, Deutsch GK et al (2020) Safety of plasma infusions in Parkinson\u2019s disease. Mov Disord 35:1905\u20131913. https:\/\/doi.org\/10.1002\/MDS.28198","journal-title":"Mov Disord"},{"key":"1368_CR137","doi-asserted-by":"publisher","first-page":"13954","DOI":"10.3390\/IJMS232213954","volume":"23","author":"E Passeri","year":"2022","unstructured":"Passeri E, Elkhoury K, Morsink M et al (2022) Alzheimer\u2019s disease: treatment strategies and their limitations. Int J Mol Sci 23:13954. https:\/\/doi.org\/10.3390\/IJMS232213954","journal-title":"Int J Mol Sci"},{"key":"1368_CR138","doi-asserted-by":"publisher","first-page":"P606","DOI":"10.1016\/J.JALZ.2017.06.652","volume":"13","author":"R Penninkilampi","year":"2017","unstructured":"Penninkilampi R, Eslick GD (2017) [P2\u2013004]: The safety and efficacy of Intravenous Immunoglobulin (IVIG) for Alzheimer\u2019s disease: a meta-analysis. Alzheimer\u2019s Dement 13:P606\u2013P606. https:\/\/doi.org\/10.1016\/J.JALZ.2017.06.652","journal-title":"Alzheimer\u2019s Dement"},{"key":"1368_CR139","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.1523\/JNEUROSCI.5066-04.2005","volume":"25","author":"L P\u00e9rez-Mart\u00ednez","year":"2005","unstructured":"P\u00e9rez-Mart\u00ednez L, Jaworski DM (2005) Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal. J Neurosci 25:4917\u20134929. https:\/\/doi.org\/10.1523\/JNEUROSCI.5066-04.2005","journal-title":"J Neurosci"},{"key":"1368_CR140","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1097\/00001756-199908020-00035","volume":"10","author":"G Perry","year":"1999","unstructured":"Perry G, Roder H, Nunomura A et al (1999) Activation of neuronal Extracellular Receptor Kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. NeuroReport 10:2411\u20132415. https:\/\/doi.org\/10.1097\/00001756-199908020-00035","journal-title":"NeuroReport"},{"key":"1368_CR141","doi-asserted-by":"publisher","DOI":"10.5772\/INTECHOPEN.94950","author":"MK Poddar","year":"2021","unstructured":"Poddar MK, Chakraborty A, Banerjee S et al (2021) Neurodegeneration: diagnosis, prevention, and therapy. Oxidoreductase. https:\/\/doi.org\/10.5772\/INTECHOPEN.94950","journal-title":"Oxidoreductase"},{"key":"1368_CR142","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.1073\/PNAS.0700337104","volume":"104","author":"P Prabhat","year":"2007","unstructured":"Prabhat P, Gan Z, Chao J et al (2007) Elucidation of intracellular recycling pathways leading to exocytosis of the Fc receptor, FcRn, by using multifocal plane microscopy. Proc Natl Acad Sci U S A 104:5889\u20135894. https:\/\/doi.org\/10.1073\/PNAS.0700337104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1368_CR143","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/J.JNEUROIM.2012.06.009","volume":"251","author":"DP Proulx","year":"2012","unstructured":"Proulx DP, Rouleau P, Par\u00e9 I et al (2012) Interaction between intravenous immunoglobulin (IVIg) and the low-density lipoprotein receptor-related protein 1: a role for transcytosis across the blood brain barrier? J Neuroimmunol 251:39\u201344. https:\/\/doi.org\/10.1016\/J.JNEUROIM.2012.06.009","journal-title":"J Neuroimmunol"},{"key":"1368_CR144","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1742-2094-9-105","volume":"9","author":"L Puli","year":"2012","unstructured":"Puli L, Pomeshchik Y, Olas K et al (2012) Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer\u2019s disease. J Neuroinflammation 9:105. https:\/\/doi.org\/10.1186\/1742-2094-9-105","journal-title":"J Neuroinflammation"},{"key":"1368_CR145","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3389\/fimmu.2019.01540","volume":"10","author":"M Pyzik","year":"2019","unstructured":"Pyzik M, Sand KMK, Hubbard JJ et al (2019) The neonatal Fc Receptor (FcRn): a misnomer? Front Immunol 10:1540. https:\/\/doi.org\/10.3389\/fimmu.2019.01540","journal-title":"Front Immunol"},{"key":"1368_CR146","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1517\/13543784.10.10.1809","volume":"10","author":"SI Rapoport","year":"2001","unstructured":"Rapoport SI (2001) Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy. Expert Opin Investig Drugs 10:1809\u20131818. https:\/\/doi.org\/10.1517\/13543784.10.10.1809","journal-title":"Expert Opin Investig Drugs"},{"key":"1368_CR147","doi-asserted-by":"publisher","first-page":"e2175","DOI":"10.1371\/JOURNAL.PONE.0002175","volume":"3","author":"SB Raymond","year":"2008","unstructured":"Raymond SB, Treat LH, Dewey JD et al (2008) Ultrasound Enhanced delivery of molecular imaging and therapeutic agents in Alzheimer\u2019s disease mouse models. PLoS One 3:e2175. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0002175","journal-title":"PLoS One"},{"key":"1368_CR148","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1038\/NCOMMS13363","volume":"7","author":"J Rebo","year":"2016","unstructured":"Rebo J, Mehdipour M, Gathwala R et al (2016) A single heterochronic blood exchange reveals rapid inhibition of multiple tissues by old blood. Nat Commun 7:13363. https:\/\/doi.org\/10.1038\/NCOMMS13363","journal-title":"Nat Commun"},{"key":"1368_CR149","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/J.ARR.2014.01.004","volume":"14","author":"A Reeve","year":"2014","unstructured":"Reeve A, Simcox E, Turnbull D (2014) Ageing and Parkinson\u2019s disease: why is advancing age the biggest risk factor? Ageing Res Rev 14:19\u201330. https:\/\/doi.org\/10.1016\/J.ARR.2014.01.004","journal-title":"Ageing Res Rev"},{"key":"1368_CR150","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/J.NEUROBIOLAGING.2007.12.021","volume":"30","author":"NR Relkin","year":"2009","unstructured":"Relkin NR, Szabo P, Adamiak B et al (2009) 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease. Neurobiol Aging 30:1728\u20131736. https:\/\/doi.org\/10.1016\/J.NEUROBIOLAGING.2007.12.021","journal-title":"Neurobiol Aging"},{"key":"1368_CR151","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1212\/WNL.0000000000003904","volume":"88","author":"NR Relkin","year":"2017","unstructured":"Relkin NR, Thomas RG, Rissman RA et al (2017) A phase 3 trial of IV immunoglobulin for Alzheimer disease. Neurology 88:1768\u20131775. https:\/\/doi.org\/10.1212\/WNL.0000000000003904","journal-title":"Neurology"},{"key":"1368_CR152","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ANA.24270","volume":"76","author":"KF Roberts","year":"2014","unstructured":"Roberts KF, Elbert DL, Kasten TP et al (2014) Amyloid-\u03b2 efflux from the CNS into the plasma. Ann Neurol 76:837\u2013844. https:\/\/doi.org\/10.1002\/ANA.24270","journal-title":"Ann Neurol"},{"key":"1368_CR153","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1210\/EN.2015-1628","volume":"156","author":"BD Rodgers","year":"2015","unstructured":"Rodgers BD, Eldridge JA (2015) Reduced circulating GDF11 is unlikely responsible for age-dependent changes in mouse heart, muscle, and brain. Endocrinology 156:3885\u20133888. https:\/\/doi.org\/10.1210\/EN.2015-1628","journal-title":"Endocrinology"},{"key":"1368_CR154","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/J.BRAINRES.2010.09.078","volume":"1366","author":"DD Rowe","year":"2010","unstructured":"Rowe DD, Leonardo CC, Hall AA et al (2010) Cord blood administration induces oligodendrocyte survival through alterations in gene expression. Brain Res 1366:172\u2013188. https:\/\/doi.org\/10.1016\/J.BRAINRES.2010.09.078","journal-title":"Brain Res"},{"key":"1368_CR155","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1074\/JBC.M111.296434","volume":"287","author":"DD Rowe","year":"2012","unstructured":"Rowe DD, Leonardo CC, Recio JA et al (2012) Human umbilical cord blood cells protect oligodendrocytes from brain ischemia through Akt signal transduction. J Biol Chem 287:4177\u20134187. https:\/\/doi.org\/10.1074\/JBC.M111.296434","journal-title":"J Biol Chem"},{"key":"1368_CR156","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/S12975-017-0545-3","volume":"8","author":"M Roy-O\u2019Reilly","year":"2017","unstructured":"Roy-O\u2019Reilly M, Ritzel RM, Conway SE et al (2017) CCL11 (Eotaxin-1) levels predict long-term functional outcomes in patients following ischemic stroke. Transl Stroke Res 8:578\u2013584. https:\/\/doi.org\/10.1007\/S12975-017-0545-3","journal-title":"Transl Stroke Res"},{"key":"1368_CR157","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1038\/S41598-020-60438-Z","volume":"10","author":"JS Ruano-Salguero","year":"2020","unstructured":"Ruano-Salguero JS, Lee KH (2020) Antibody transcytosis across brain endothelial-like cells occurs nonspecifically and independent of FcRn. Sci Rep 10:3685. https:\/\/doi.org\/10.1038\/S41598-020-60438-Z","journal-title":"Sci Rep"},{"key":"1368_CR158","doi-asserted-by":"publisher","first-page":"e12073","DOI":"10.1002\/TRC2.12073","volume":"6","author":"SP Salloway","year":"2020","unstructured":"Salloway SP, Sevingy J, Budur K et al (2020) Advancing combination therapy for Alzheimer\u2019s disease. Alzheimer\u2019s Dement 6:e12073. https:\/\/doi.org\/10.1002\/TRC2.12073","journal-title":"Alzheimer\u2019s Dement"},{"key":"1368_CR159","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2147\/DNND.S51786","volume":"4","author":"K Schindowski","year":"2014","unstructured":"Schindowski K, Schindowski C, Zimmermann J (2014) Intravenous immunoglobulin for the treatment of Alzheimer\u2019s disease: current evidence and considerations. Degener Neurol Neuromuscul Dis 4:121\u2013130. https:\/\/doi.org\/10.2147\/DNND.S51786","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"1368_CR160","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1046\/J.1471-4159.2002.00840.X","volume":"81","author":"F Schlachetzki","year":"2002","unstructured":"Schlachetzki F, Zhu C, Pardridge WM (2002) Expression of the neonatal Fc receptor (FcRn) at the blood-brain barrier. J Neurochem 81:203\u2013206. https:\/\/doi.org\/10.1046\/J.1471-4159.2002.00840.X","journal-title":"J Neurochem"},{"key":"1368_CR161","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1001\/JAMANEUROL.2018.3288","volume":"76","author":"SJ Sha","year":"2019","unstructured":"Sha SJ, Deutsch GK, Tian L et al (2019) Safety, tolerability, and feasibility of young plasma infusion in the plasma for alzheimer symptom amelioration study: a randomized clinical trial. JAMA Neurol 76:35\u201340. https:\/\/doi.org\/10.1001\/JAMANEUROL.2018.3288","journal-title":"JAMA Neurol"},{"key":"1368_CR162","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5535\/ARM.22027","volume":"46","author":"JH Shin","year":"2022","unstructured":"Shin JH (2022) Dementia epidemiology fact sheet 2022. Ann Rehabil Med 46:53\u201359. https:\/\/doi.org\/10.5535\/ARM.22027","journal-title":"Ann Rehabil Med"},{"key":"1368_CR163","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1126\/SCIENCE.1251152","volume":"344","author":"M Sinha","year":"2014","unstructured":"Sinha M, Jang YC, Oh J et al (2014) Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science 344:649\u2013652. https:\/\/doi.org\/10.1126\/SCIENCE.1251152","journal-title":"Science"},{"key":"1368_CR164","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/S12640-018-9937-8","volume":"35","author":"S Sirivichayakul","year":"2019","unstructured":"Sirivichayakul S, Kanchanatawan B, Thika S et al (2019) Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), is a major contributor to cognitive decline in normal people and to executive, memory, and sustained attention deficits, formal thought disorders, and psychopathology in schizophrenia patients. Neurotox Res 35:122\u2013138. https:\/\/doi.org\/10.1007\/S12640-018-9937-8","journal-title":"Neurotox Res"},{"key":"1368_CR165","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/NM.3898","volume":"21","author":"LK Smith","year":"2015","unstructured":"Smith LK, He Y, Park JS et al (2015a) \u03b22-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis. Nat Med 21:932\u2013937. https:\/\/doi.org\/10.1038\/NM.3898","journal-title":"Nat Med"},{"key":"1368_CR166","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1161\/CIRCRESAHA.115.307527","volume":"117","author":"SC Smith","year":"2015","unstructured":"Smith SC, Zhang X, Zhang X et al (2015b) GDF11 does not rescue aging-related pathological hypertrophy. Circ Res 117:926\u2013932. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.307527","journal-title":"Circ Res"},{"key":"1368_CR167","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1038\/jcbfm.2013.160","volume":"33","author":"I St-Amour","year":"2013","unstructured":"St-Amour I, Par\u00e9 I, Alata W et al (2013) Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier. J Cereb Blood Flow Metab 33:1983\u20131992. https:\/\/doi.org\/10.1038\/jcbfm.2013.160","journal-title":"J Cereb Blood Flow Metab"},{"key":"1368_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-11-54","volume":"11","author":"I St-Amour","year":"2014","unstructured":"St-Amour I, Par\u00e9 I, Tremblay C et al (2014) IVIg protects the 3xTg-AD mouse model of Alzheimer\u2019s disease from memory deficit and A\u03b2 pathology. J Neuroinflammation 11:1\u201316. https:\/\/doi.org\/10.1186\/1742-2094-11-54","journal-title":"J Neuroinflammation"},{"key":"1368_CR169","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/S12031-012-9783-8","volume":"48","author":"HDV Starkey","year":"2012","unstructured":"Starkey HDV, Van Kirk CA, Bixler GV et al (2012) Neuroglial expression of the MHCI pathway and PirB receptor is upregulated in the hippocampus with advanced aging. J Mol Neurosci 48:111\u2013126. https:\/\/doi.org\/10.1007\/S12031-012-9783-8","journal-title":"J Mol Neurosci"},{"key":"1368_CR170","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1126\/SCIENCE.286.5448.2352","volume":"286","author":"J Tan","year":"1999","unstructured":"Tan J, Town T, Paris D et al (1999) Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science 286:2352\u20132355. https:\/\/doi.org\/10.1126\/SCIENCE.286.5448.2352","journal-title":"Science"},{"key":"1368_CR171","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fpsyt.2018.00241","volume":"9","author":"AL Teixeira","year":"2018","unstructured":"Teixeira AL, Gama CS, Rocha NP, Teixeira MM (2018) Revisiting the role of eotaxin-1\/CCL11 in psychiatric disorders. Front Psychiatry 9:241. https:\/\/doi.org\/10.3389\/fpsyt.2018.00241","journal-title":"Front Psychiatry"},{"key":"1368_CR172","doi-asserted-by":"publisher","first-page":"e247","DOI":"10.1016\/J.LPM.2016.06.016","volume":"45","author":"JD Tissot","year":"2016","unstructured":"Tissot JD, Garraud O (2016) Ethics and blood donation: a marriage of convenience. Presse Med 45:e247\u2013e252. https:\/\/doi.org\/10.1016\/J.LPM.2016.06.016","journal-title":"Presse Med"},{"key":"1368_CR173","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/BIOMEDICINES11020328","volume":"11","author":"DG Tonev","year":"2023","unstructured":"Tonev DG, Momchilova AB (2023) Therapeutic plasma exchange in certain immune-mediated neurological disorders: focus on a novel nanomembrane-based technology. Biomedicines 11:328. https:\/\/doi.org\/10.3390\/BIOMEDICINES11020328","journal-title":"Biomedicines"},{"key":"1368_CR174","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/EJI.200425585","volume":"35","author":"KP Townsend","year":"2005","unstructured":"Townsend KP, Town T, Mori T et al (2005) CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide. Eur J Immunol 35:901\u2013910. https:\/\/doi.org\/10.1002\/EJI.200425585","journal-title":"Eur J Immunol"},{"key":"1368_CR175","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/NBT1143","volume":"23","author":"C Vaccaro","year":"2005","unstructured":"Vaccaro C, Zhou J, Ober RJ, Ward ES (2005) Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels. Nat Biotechnol 23:1283\u20131288. https:\/\/doi.org\/10.1038\/NBT1143","journal-title":"Nat Biotechnol"},{"key":"1368_CR176","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000509119","volume":"30","author":"B Varkey","year":"2021","unstructured":"Varkey B (2021) Principles of clinical ethics and their application to practice. Med Princ Pract 30:17\u201328. https:\/\/doi.org\/10.1159\/000509119","journal-title":"Med Princ Pract"},{"key":"1368_CR177","doi-asserted-by":"publisher","first-page":"25658","DOI":"10.1038\/srep25658","volume":"6","author":"R Villasen\u00f5r","year":"2016","unstructured":"Villasen\u00f5r R, Ozmen L, Messaddeq N et al (2016) Trafficking of endogenous immunoglobulins by endothelial cells at the blood-brain barrier. Sci Rep 6:25658. https:\/\/doi.org\/10.1038\/srep25658","journal-title":"Sci Rep"},{"key":"1368_CR178","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/NATURE10357","volume":"477","author":"SA Villeda","year":"2011","unstructured":"Villeda SA, Luo J, Mosher KI et al (2011) The aging systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477:90\u201394. https:\/\/doi.org\/10.1038\/NATURE10357","journal-title":"Nature"},{"key":"1368_CR179","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/NM.3569","volume":"20","author":"SA Villeda","year":"2014","unstructured":"Villeda SA, Plambeck KE, Middeldorp J et al (2014) Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat Med 20:659\u2013663. https:\/\/doi.org\/10.1038\/NM.3569","journal-title":"Nat Med"},{"key":"1368_CR180","doi-asserted-by":"publisher","first-page":"e12114","DOI":"10.1002\/TRC2.12114","volume":"6","author":"MP Vitek","year":"2020","unstructured":"Vitek MP, Araujo JA, Fosse M et al (2020) Translational animal models for Alzheimer\u2019s disease: an Alzheimer\u2019s association business consortium think tank. Alzheimer\u2019s Dement 6:e12114. https:\/\/doi.org\/10.1002\/TRC2.12114","journal-title":"Alzheimer\u2019s Dement"},{"key":"1368_CR181","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1166\/JBN.2016.2181","volume":"12","author":"J Wang","year":"2016","unstructured":"Wang J, Li P, Tian R et al (2016) A novel microbubble capable of ultrasound-triggered release of drug-loaded nanoparticles. J Biomed Nanotechnol 12:516\u2013524. https:\/\/doi.org\/10.1166\/JBN.2016.2181","journal-title":"J Biomed Nanotechnol"},{"key":"1368_CR182","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","volume":"57","author":"R Wang","year":"2017","unstructured":"Wang R, Reddy PH (2017) Role of glutamate and NMDA receptors in Alzheimer\u2019s disease. J Alzheimers Dis 57:1041\u20131048. https:\/\/doi.org\/10.3233\/JAD-160763","journal-title":"J Alzheimers Dis"},{"key":"1368_CR183","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/INTIMM\/DXG018","volume":"15","author":"ES Ward","year":"2003","unstructured":"Ward ES, Zhou J, Ghetie V, Ober RJ (2003) Evidence to support the cellular mechanism involved in serum IgG homeostasis in humans. Int Immunol 15:187\u2013195. https:\/\/doi.org\/10.1093\/INTIMM\/DXG018","journal-title":"Int Immunol"},{"key":"1368_CR184","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/J.1471-4159.2012.07754.X","volume":"122","author":"A Widiapradja","year":"2012","unstructured":"Widiapradja A, Vegh V, Lok KZ et al (2012) Intravenous immunoglobulin (IVIg) protects neurons against amyloid beta-peptide toxicity and ischemic stroke by attenuating multiple cell death pathways. J Neurochem 122:321\u2013332. https:\/\/doi.org\/10.1111\/J.1471-4159.2012.07754.X","journal-title":"J Neurochem"},{"key":"1368_CR185","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.nbd.2003.09.015","volume":"15","author":"DM Wilcock","year":"2004","unstructured":"Wilcock DM, Munireddy SK, Rosenthal A et al (2004a) Microglial activation facilitates A\u03b2 plaque removal following intracranial anti-A\u03b2 antibody administration. Neurobiol Dis 15:11\u201320. https:\/\/doi.org\/10.1016\/j.nbd.2003.09.015","journal-title":"Neurobiol Dis"},{"key":"1368_CR186","doi-asserted-by":"publisher","first-page":"6144","DOI":"10.1523\/JNEUROSCI.1090-04.2004","volume":"24","author":"DM Wilcock","year":"2004","unstructured":"Wilcock DM, Rojiani A, Rosenthal A et al (2004b) Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition. J Neurosci 24:6144\u20136151. https:\/\/doi.org\/10.1523\/JNEUROSCI.1090-04.2004","journal-title":"J Neurosci"},{"key":"1368_CR187","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41531-022-00410-y","volume":"8","author":"AW Willis","year":"2022","unstructured":"Willis AW, Roberts E, Beck JC et al (2022) Incidence of Parkinson disease in North America. NPJ Parkinsons Dis 8:170. https:\/\/doi.org\/10.1038\/s41531-022-00410-y","journal-title":"NPJ Parkinsons Dis"},{"key":"1368_CR188","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1210\/ENDO.142.3.8033","volume":"142","author":"PM Wise","year":"2001","unstructured":"Wise PM, Dubal DB, Wilson ME et al (2001) Minireview: neuroprotective effects of estrogen\u2014new insights into mechanisms of action. Endocrinology 142:969\u2013973. https:\/\/doi.org\/10.1210\/ENDO.142.3.8033","journal-title":"Endocrinology"},{"key":"1368_CR189","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/NATURE20411","volume":"539","author":"T Wyss-Coray","year":"2016","unstructured":"Wyss-Coray T (2016) Ageing, neurodegeneration and brain rejuvenation. Nature 539:180\u2013186. https:\/\/doi.org\/10.1038\/NATURE20411","journal-title":"Nature"},{"key":"1368_CR190","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/S00401-015-1477-1","volume":"130","author":"Y Xiang","year":"2015","unstructured":"Xiang Y, Le BuX, Liu YH et al (2015) Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer\u2019s disease. Acta Neuropathol 130:487\u2013499. https:\/\/doi.org\/10.1007\/S00401-015-1477-1","journal-title":"Acta Neuropathol"},{"key":"1368_CR191","doi-asserted-by":"publisher","first-page":"648740","DOI":"10.1155\/2014\/648740","volume":"2014","author":"A Xie","year":"2014","unstructured":"Xie A, Gao J, Xu L, Meng D (2014) Shared Mechanisms of Neurodegeneration in Alzheimer\u2019s disease and Parkinson\u2019s disease. Biomed Res Int 2014:648740. https:\/\/doi.org\/10.1155\/2014\/648740","journal-title":"Biomed Res Int"},{"key":"1368_CR192","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4062\/BIOMOLTHER.2012.20.3.245","volume":"20","author":"SS Yoon","year":"2012","unstructured":"Yoon SS, Jo SA (2012) Mechanisms of amyloid-\u03b2 peptide clearance: potential therapeutic targets for Alzheimer\u2019s disease. Biomol Ther (Seoul) 20:245\u2013255. https:\/\/doi.org\/10.4062\/BIOMOLTHER.2012.20.3.245","journal-title":"Biomol Ther (Seoul)"},{"key":"1368_CR193","doi-asserted-by":"publisher","unstructured":"Yousef H, Conboy MJ, Morgenthaler A et al (2015) Systemic attenuation of the TGF-\u03b2 pathway by a single drug simultaneously rejuvenates hippocampal neurogenesis and myogenesis in the same old mammal. Oncotarget 6:11959\u201311978. https:\/\/doi.org\/10.18632\/ONCOTARGET.3851","DOI":"10.18632\/ONCOTARGET.3851"},{"key":"1368_CR194","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0165-5728(01)00242-9","volume":"114","author":"Y Zhang","year":"2001","unstructured":"Zhang Y, Pardridge WM (2001) Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier. J Neuroimmunol 114:168\u2013172. https:\/\/doi.org\/10.1016\/S0165-5728(01)00242-9","journal-title":"J Neuroimmunol"},{"key":"1368_CR195","doi-asserted-by":"publisher","unstructured":"Zhao J, Liu X, Xia W et al (2020a) Targeting Amyloidogenic Processing of APP in Alzheimer\u2019s Disease. Front Mol Neurosci 13:. https:\/\/doi.org\/10.3389\/FNMOL.2020.00137","DOI":"10.3389\/FNMOL.2020.00137"},{"key":"1368_CR196","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/S13195-020-00639-W","volume":"12","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Qian R, Zhang J et al (2020b) Young blood plasma reduces Alzheimer\u2019s disease-like brain pathologies and ameliorates cognitive impairment in 3\u00d7Tg-AD mice. Alzheimers Res Ther 12:70. https:\/\/doi.org\/10.1186\/S13195-020-00639-W","journal-title":"Alzheimers Res Ther"},{"key":"1368_CR197","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1046\/J.1471-4159.2003.01820.X","volume":"86","author":"X Zhu","year":"2003","unstructured":"Zhu X, Sun Z, Lee H gon et al (2003) Distribution, levels, and activation of MEK1 in Alzheimer\u2019s disease. J Neurochem 86:136\u2013142. https:\/\/doi.org\/10.1046\/J.1471-4159.2003.01820.X","journal-title":"J Neurochem"},{"key":"1368_CR198","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/ANE.12444","volume":"133","author":"S \u017divkovi\u0107","year":"2016","unstructured":"\u017divkovi\u0107 S (2016) Intravenous immunoglobulin in the treatment of neurologic disorders. Acta Neurol Scand 133:84\u201396. https:\/\/doi.org\/10.1111\/ANE.12444","journal-title":"Acta Neurol Scand"},{"key":"1368_CR199","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/J.1471-4159.2004.02385.X","volume":"89","author":"BV Zlokovic","year":"2004","unstructured":"Zlokovic BV (2004) Clearing amyloid through the blood-brain barrier. J Neurochem 89:807\u2013811. https:\/\/doi.org\/10.1111\/J.1471-4159.2004.02385.X","journal-title":"J Neurochem"},{"key":"1368_CR200","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0014-4886(90)90144-H","volume":"107","author":"BV Zlokovic","year":"1990","unstructured":"Zlokovic BV, Skundric DS, Segal MB et al (1990) A saturable mechanism for transport of immunoglobulin G across the blood-brain barrier of the guinea pig. Exp Neurol 107:263\u2013270. https:\/\/doi.org\/10.1016\/0014-4886(90)90144-H","journal-title":"Exp Neurol"},{"key":"1368_CR201","unstructured":"Zo\u00eb Corbyn (2020) Could \u2018young\u2019 blood stop us getting old? The Guardian"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-024-01368-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-024-01368-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-024-01368-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T04:09:51Z","timestamp":1720498191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-024-01368-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":201,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["1368"],"URL":"https:\/\/doi.org\/10.1007\/s11011-024-01368-x","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,6]]},"assertion":[{"value":"27 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the authors declare no conflicts of interest, financial or otherwise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}